Acquisition provides Pfizer with a preclinical CMV vaccine candidate
- Details
- Category: Pfizer
Pfizer Inc. has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. This transaction provides access to a preclinical human cytomegalovirus (CMV) vaccine candidate, as well as intellectual property and a technology platform related to a second, undisclosed vaccine program.
Novartis collaborates with Intellia Therapeutics and Caribou Biosciences
- Details
- Category: Novartis
Novartis announced today that it has signed collaboration and licensing agreements with Intellia Therapeutics for the discovery and development of new medicines using CRISPR genome editing technology and Caribou Biosciences for the development of drug discovery tools. Intellia and Caribou are two of the leading biotechnology companies developing this novel technology.
Bristol-Myers Squibb and California Institute for Biomedical Research (Calibr) sign worldwide research collaboration
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) and the California Institute for Biomedical Research (Calibr) announced today they have entered into a worldwide research collaboration to develop novel small molecule anti-fibrotic therapies, and an exclusive license agreement that allows Bristol-Myers Squibb to develop, manufacture and commercialize Calibr's preclinical compounds resulting from the collaboration.
New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
- Details
- Category: GlaxoSmithKline
A new European consortium has been formed including GSK and three leading research institutions to help further advance development of a candidate vaccine against Ebola, which is being co-developed by GSK and the US National Institutes of Health (NIH).
Abbott completes acquisition of Veropharm
- Details
- Category: Abbott
Abbott (NYSE: ABT) today announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Abbott has had a presence in Russia for nearly 40 years and, in line with its long-term commitment to growing global healthcare markets and capabilities, the company is committed to providing a reliable supply of its healthcare products to Russian patients.
Pfizer expands rare disease research with establishment of gene therapy platform
- Details
- Category: Pfizer
Pfizer Inc. (NYSE:PFE) announced today two strategic decisions to expand the company's rare disease research and development activities through the establishment of a gene therapy platform to investigate potential treatments for patients.
Jury verdict favours AstraZeneca in Nexium antitrust litigation
- Details
- Category: AstraZeneca
AstraZeneca today announced that a jury in the US District Court for the District of Massachusetts returned a verdict in favour of AstraZeneca in a Multi-District antitrust case filed by various purchaser groups challenging the previous settlement of Nexium patent litigation with Ranbaxy.
More Pharma News ...
- Bristol-Myers Squibb Foundation awards nine grants to support care for high-risk patients with hepatitis B and C in China and India
- Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
- GSK statement on first phase 1 trial results of a candidate Ebola vaccine
- Bristol-Myers Squibb and Five Prime Therapeutics announce exclusive clinical collaboration
- Novartis Foundation symposium showcases sustainable healthcare interventions
- Two new, large scale real-world analyses show fewer major bleeds and strokes with Pradaxa® than with warfarin
- Novo Nordisk second best in the world at providing access to medicine